ResearchMoz

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014

GlobalData
Published Date » 2014-06-20
No. Of Pages » 159
   
 Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014 provides data on the Bipolar Disorder (Manic Depression) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bipolar Disorder (Manic Depression). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bipolar Disorder (Manic Depression). This report is built using data and information sourced from proprietary databases, primary and secondary research and...
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bipolar Disorder (Manic Depression) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bipolar Disorder (Manic Depression) 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Bipolar Disorder (Manic Depression) 38
Mar 31, 2014: Forest Laboratories and Gedeon Richter Announce Positive Phase IIb Topline Results for Cariprazine for the Treatment of Bipolar Depression 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Eli Lilly and Company 44
Clinical Trial Overview of Eli Lilly and Company 44
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Johnson & Johnson 50
Clinical Trial Overview of Johnson & Johnson 50
Otsuka Holdings Co., Ltd. 53
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 53
GlaxoSmithKline plc 56
Clinical Trial Overview of GlaxoSmithKline plc 56
Abbott Laboratories 58
Clinical Trial Overview of Abbott Laboratories 58
Merck & Co., Inc. 60
Clinical Trial Overview of Merck & Co., Inc. 60
Bristol-Myers Squibb Company 62
Clinical Trial Overview of Bristol-Myers Squibb Company 62
Novartis AG 64
Clinical Trial Overview of Novartis AG 64
Clinical Trial Overview of Top Institutes / Government 66
National Institute of Mental Health 66
Clinical Trial Overview of National Institute of Mental Health 66
Massachusetts General Hospital 69
Clinical Trial Overview of Massachusetts General Hospital 69
University of Pittsburgh 72
Clinical Trial Overview of University of Pittsburgh 72
U.S. Department of Veterans Affairs 73
Clinical Trial Overview of U.S. Department of Veterans Affairs 73
Mclean Hospital 74
Clinical Trial Overview of Mclean Hospital 74
University of Texas Southwestern Medical Center at Dallas 75
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 75
University of Cincinnati 76
Clinical Trial Overview of University of Cincinnati 76
University of British Columbia 77
Clinical Trial Overview of University of British Columbia 77
University Hospitals of Cleveland 78
Clinical Trial Overview of University Hospitals of Cleveland 78
Lindner Center of HOPE 79
Clinical Trial Overview of Lindner Center of HOPE 79
Five Key Clinical Profiles 80

Appendix 157
Abbreviations 157
Definitions 157
Research Methodology 158
Secondary Research 158
About GlobalData 159
Contact Us 159
Disclaimer 159
Source 159

List of Tables


Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bipolar Disorder (Manic Depression) Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Bipolar Disorder (Manic Depression) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Bipolar Disorder (Manic Depression) Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 33
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 39
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 44
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 47
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 50
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 53
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 56
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 58
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 60
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 62
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 64
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 66
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 69
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 72
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 73
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2014* 74
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2014* 75
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014* 76
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 77
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Cleveland, 2014* 78
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Lindner Center of HOPE, 2014* 79

List of Figures


Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 33
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 35
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
GlobalData Methodology 158

Upcoming Reports:

Greece: market of industrial machinery for the preparation of fruits, nuts or vegetables
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the industrial machinery for the preparation of fruits, nuts or vegetables market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the industrial machinery for the preparation of fruits, nuts or vegetables market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build...
Diameter Signaling Control Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Diameter signaling controllers are used to lessen diameter traffic congestion and allow signaling and control plane within the networks.  Some of the factors such as technological improvements and congestion of network traffic are forcing operators to utilize diameter signaling controllers for efficiently managing and scaling data traffic.   Some of the major factors responsible for increase in data signaling traffic is growing use of mobile broadband networks, new communication devices, smart phones, and other mobile applications like gaming and social networking...
Voice Verification Market - Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Voice verification technology enables identification of an individual on the basis of voice biometrics. Its works in the same manner as blood DNA and fingerprint matching enables identification of individual. Its main application is in verification of financial transactions to guard against frauds. By assigning proper combination of voice biometrics, consumers can use their own unique voice to authorize transactions, signing and protecting personal data thus reducing risk of fraud and identity theft by making highly secure environment.  The market is in it nascent...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

A Health Tech Incubator Started by GE Healthcare
Oct 30, 2014  
For the very first time, a health tech start up campus has been established by GE Healthcare at its headquarters at Helsinki, Finland. This area already has about twenty such healthcare start ups that are working on cloud services, wireless technologies, apps, and sensors that aim at improving healthcare. The main rationale behind such a step is providing opportunities for further...
Net Earnings of DuPont Increases 52% despite Agricultural Turmoil
Oct 29, 2014  
DuPont - The Wilmington, Del-based leading chemical company faced decline of three percent sales to $7.5 billion in the quarter ending of September 30. The company’s third-quarter earnings were increased by 52 percent to $433 million albeit the slow global growth and agricultural downside.   The company witnessed the biggest drags from chemical sales with eight percent...
Appeal for Sanitization in Construction Industry through Government Regulations: CIOB Ghana
Oct 29, 2014  
Rockson Dogbegah - The Chairman of the Chartered Institute of Building Ghana commented that the construction industry needs a thorough cleaning up and assurance of proper growth. Mr. Dogbegah also said that a few factors are extremely important for a proper development in the construction industry. These include keen adherence to standards, supreme sense of professionalism, and sheer pursuance...
Facebook Hints of Rise in Expenses in 2015, Shares Drop
Oct 29, 2014  
Facebook has announced on Tuesday that it is prepping for a dramatic rise in spending in the year 2015. This warning has come combined with a projected slowdown in the company’s revenues after revenues were analyzed at the end of the third quarter of the year. The plans of such hefty spending in the next financial year by the company are indicative of stress in the investor...
Samsung Records Poorest Profits in Q3 2014
Oct 29, 2014  
In the quarter ending September 2014, Samsung Electronics Co. Ltd registered the smallest earnings ever in two years. The drop in earnings can be easily attributed to heavy competition from new Chinese devices and the Apple phones. The net income stood at US$4 billion for the South Korea-based company. Apple has been Samsung’s strongest contender ever since the latter entered the...